Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow AVTR
Avantor, Inc. (AVTR) P/E ratio
Avantor, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 341× (January 2021) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 20.1× | (57.66%) |
| FY2023 | 47.4× | 130.60% |
| FY2022 | 20.6× | (58.05%) |
| FY2021 | 49.0× | (84.33%) |
| FY2020 | 313× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 28 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| AVTR Avantor, Inc. | n/m |
| TFX Teleflex Incorporated compare | n/m |
| SOLV Solventum Corporation compare | 10.4× |
| COO The Cooper Companies, Inc. compare | 19.8× |
| ATR AptarGroup, Inc. compare | 22.2× |
| ALGN Align Technology, Inc. compare | 25.6× |
| RGEN Repligen Corporation compare | 234× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)